Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2013 - 2019)

Armata Pharmaceuticals has reported Other Non-Current Liabilities for 7 years, with the latest figure at $1.3 million in Q4 2019.

• Quarterly Other Non-Current Liabilities rose 20.59% year-over-year to $1.3 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.3 million (up 20.59% YoY) and the FY2019 annual result came in at $1.3 million, up 20.59% from the prior year.
• Other Non-Current Liabilities grew to $1.3 million in Q4 2019 per ARMP's latest filing, from $1.2 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $14.7 million in Q1 2015 and troughed at $2000.0 in Q1 2016.
• A 5-year average of $2.4 million and a median of $1.2 million in 2019 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2016 and 2017: Other Non-Current Liabilities slumped 99.99% in 2016, then soared 116350.0% in 2017.
• Over 5 years, Other Non-Current Liabilities stood at $1.5 million in 2015, then jumped by 62.98% to $2.4 million in 2016, then tumbled by 88.05% to $292000.0 in 2017, then jumped by 282.53% to $1.1 million in 2018, then rose by 20.59% to $1.3 million in 2019.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.3 million, $1.2 million, and $1.2 million for Q4 2019, Q3 2019, and Q1 2019 respectively.